Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,954,533
+$1,841,086 QoQ
Shares Held
255,495
+1992.2% QoQ
Ownership
0.304%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. REPL ranks #99 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in REPL
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,954,533 | 255,495 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $113,447 | 12,212 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $129,195 | 13,251 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $185,390 | 15,309 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $304,533 | 27,786 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $150,264 | 17,825 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $262,153 | 11,290 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $197,156 | 11,164 | Shares | Defined | 2023-05-15 | |
| 2021-06-30 | $587,019 | 15,279 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $605,379 | 19,842 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,083,612 | 28,404 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $905,307 | 39,327 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $884,386 | 35,589 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $444,173 | 44,551 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||